RPS20 and glioblastoma: In newly diagnosed primary GBM, the HR for patients with overexpressed proteins RPS11 or RPS20 was 1.98 (95% C.I. 0.52–7.48, p = 0.32), when compared to patients with low RPS11 or RPS20.